- Home
- BHK vs ORGO Comparison
BHK vs ORGO Comparison
Compare BHK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHK
- ORGO
- Stock Information
- Founded
- BHK 2001
- ORGO 1985
- Country
- BHK United States
- ORGO United States
- Employees
- BHK N/A
- ORGO N/A
- Industry
- BHK Finance Companies
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- BHK Finance
- ORGO Health Care
- Exchange
- BHK Nasdaq
- ORGO Nasdaq
- Market Cap
- BHK 609.2M
- ORGO 665.8M
- IPO Year
- BHK N/A
- ORGO N/A
- Fundamental
- Price
- BHK $10.89
- ORGO $4.28
- Analyst Decision
- BHK
- ORGO Buy
- Analyst Count
- BHK 0
- ORGO 2
- Target Price
- BHK N/A
- ORGO $5.50
- AVG Volume (30 Days)
- BHK 188.3K
- ORGO 1.3M
- Earning Date
- BHK 01-01-0001
- ORGO 05-08-2025
- Dividend Yield
- BHK 8.34%
- ORGO N/A
- EPS Growth
- BHK N/A
- ORGO N/A
- EPS
- BHK 1.03
- ORGO N/A
- Revenue
- BHK N/A
- ORGO $482,043,000.00
- Revenue This Year
- BHK N/A
- ORGO N/A
- Revenue Next Year
- BHK N/A
- ORGO $7.62
- P/E Ratio
- BHK $10.42
- ORGO N/A
- Revenue Growth
- BHK N/A
- ORGO 11.29
- 52 Week Low
- BHK $9.02
- ORGO $2.17
- 52 Week High
- BHK $11.09
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- BHK 64.06
- ORGO 43.72
- Support Level
- BHK $10.65
- ORGO $4.80
- Resistance Level
- BHK $10.80
- ORGO $5.57
- Average True Range (ATR)
- BHK 0.09
- ORGO 0.32
- MACD
- BHK 0.01
- ORGO -0.15
- Stochastic Oscillator
- BHK 85.88
- ORGO 3.73
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.